130581-13-4 ((Eplivanserin (mixture))

2-Propen-1-one, 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-,O-[2-(dimethylamino)ethyl]oxime, (2E)-;SR-46349 (mixture);Eplivanserin (mixture);SR-46349;4-[(E,3Z)-3-[2-(dimethylamino)ethoxyimino]-3-(2-fluorophenyl)prop-1-enyl]phenol;BDBM50590657;PDSP1_001573;SR46349;BCP9000653;NSC_6438382;2-Propen-1-one, 1-(2-fluorophenyl)-3-(4-hyddroxyphenyl)-, O-(2-(dimethylamino)ethyl)oxime, (Z,E)-;UNII-3CO94WO6DJ;PDSP2_001557;AKOS040733116;(E)-2'-Fluoro-4-hydroxychalcone (Z)-O-(2-(dimethylamino)ethyl)oxime;SS-3097;4-[(1E,3Z)-3-{[2-(Dimethylamino)ethoxy]imino}-3-(2-fluorophenyl)prop-1-enyl]phenol;Eplivanserin [INN];BDBM81780;SR-01000944919;(E)-1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-2-propen-1-one O-[2-(dimethylamino)ethyl]oxime;SCHEMBL341108;AKOS015911838;SCHEMBL678700;SR 46349B;2-PROPEN-1-ONE, 1-(2-FLUOROPHENYL)-3-(4-HYDROXYPHENYL)-, O-(2-(DIMETHYLAMINO)ETHYL)OXIME, (1Z,2E)-;CHEMBL257704;DB12177;EPLIVANSERIN [USAN];Eplivanserin;Eplivanserine;SR-01000944919-1;130579-75-8;Eplivanserin (USAN/INN);SR46349B;CAS_6438382;MS-24923;(E)-2'-Fluoro-4-hydroxychalcone (Z)-o-(2-(dimethylamino)ethyl)oxime.;HY-10792A;3CO94WO6DJ;L001389;CS-0093050;Eplivanserin [USAN:INN:BAN];130581-13-4;D10006;

VAIOZOCLKVMIMN-PRJWTAEASA-N

1S/C19H21FN2O2/c1-22(2)13-14-24-21-19(17-5-3-4-6-18(17)20)12-9-15-7-10-16(23)11-8-15/h3-12,23H,13-14H2,1-2H3/b12-9+,21-19-

FC1C=CC=CC=1/C(/C=C/C1C=CC(=CC=1)O)=N\OCCN(C)C